CEO received an award of 122K CBT derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Nov 19, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Nov 21, 2025
CEOGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001193125-25-291554
- Filed / recorded
Nov 21, 2025, 10:00 PM UTCAdded to OQROOct 6, 2026, 7:14 PM UTC Data qualityVerified: identifiers matched exactly Reporting personSean D Keohane RelationshipDirector, Officer Officer titlePresident and CEO SecurityEmployee Stock Option (Right to Buy) TableDerivative (Table II) Transaction dateNov 19, 2025 Acquired / disposedAcquired (A) Shares owned after122,114 Footnotes from the filing
- The option vests over a three year period as follows: 30% on November 19, 2026, 30% on November 19, 2027 and 40% on November 19, 2028.
Around the same time
Traded Dec 12, 2025 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Dec 12, 2025 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Dec 12, 2025 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.